반려동물 통증 관리 의약품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Pet Pain Management Drugs Market size is expected to reach USD 5.27 Billion in 2034 from USD 2.93 Billion (2025) growing at a CAGR of 6.72% during 2026-2034.

The global pet pain management drugs market is growing significantly due to increasing pet ownership and rising awareness about animal health. Pet owners are increasingly seeking advanced veterinary treatments to ensure the well-being of their animals. The growing prevalence of chronic conditions such as arthritis and post-surgical pain in pets is driving demand for effective pain management drugs. Additionally, the humanization of pets and willingness to spend on veterinary care are supporting market growth.

Advancements in veterinary pharmaceuticals are further contributing to market expansion. New drug formulations, including non-steroidal anti-inflammatory drugs (NSAIDs) and biologics, are improving treatment outcomes. The expansion of veterinary clinics and hospitals is also increasing access to advanced pain management solutions. Furthermore, increasing research and development activities in animal healthcare are leading to the introduction of innovative therapies.

In the coming years, the pet pain management drugs market is expected to grow steadily as pet ownership continues to rise. The increasing focus on animal welfare and advancements in veterinary medicine will drive further adoption of pain management treatments. Additionally, the development of safer and more effective drugs will support long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• NSAIDs
• Opioids
• Anesthetics
• Alpha-2 agonists
• Other Types

By Route of Administration

• Oral
• Parenteral
• Topical

By Application

• Joint Pain
• Cancer Pain
• Postoperative Pain
• Other Applications

By Distribution Channel

• Veterinary Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Animal Type

• Companion animals (Dogs, Cats, Horses, Others)
• Livestock animals (Cattle, Swine, Others)

COMPANIES PROFILED

• Alivira Animal Health, Boehringer Ingelheim, Ceva Sant Animale, Chanelle Pharma, Dechra Pharmaceuticals, Elanco Animal Health, KLaser USA, Merck, Multi Radiance Medical, Norbrook, Vetoquinol, Zoetis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. NSAIDs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Opioids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Anesthetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Alpha-2 agonists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Joint Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cancer Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Postoperative Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Animal Type
• 8.2. Companion animals (Dogs, Cats, Horses, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Livestock animals (Cattle, Swine, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Route Of Administration
  • 9.2.3 By Application
  • 9.2.4 By Distribution Channel
  • 9.2.5 By Animal Type
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Route Of Administration
  • 9.3.3 By Application
  • 9.3.4 By Distribution Channel
  • 9.3.5 By Animal Type
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Route Of Administration
  • 9.4.3 By Application
  • 9.4.4 By Distribution Channel
  • 9.4.5 By Animal Type
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Route Of Administration
  • 9.5.3 By Application
  • 9.5.4 By Distribution Channel
  • 9.5.5 By Animal Type
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Route Of Administration
  • 9.6.3 By Application
  • 9.6.4 By Distribution Channel
  • 9.6.5 By Animal Type
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PET PAIN MANAGEMENT DRUGS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Alivira Animal Health
  • 11.2.2 Boehringer Ingelheim
  • 11.2.3 Ceva Sante Animale
  • 11.2.4 Chanelle Pharma
  • 11.2.5 Dechra Pharmaceuticals
  • 11.2.6 Elanco Animal Health
  • 11.2.7 K-Laser USA
  • 11.2.8 Merck
  • 11.2.9 Multi Radiance Medical
  • 11.2.10 Norbrook
  • 11.2.11 Vetoquinol
  • 11.2.12 Zoetis